mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.005 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.007 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.008 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.008 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.008 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.009 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.009 |